4/A: Semler Scientific Director Amends Filing to Reflect Transfer of Shares to Family Trust
SEC Form 4/A Filing
A Semler Scientific director amended a previous filing to reflect the transfer of shares received as director compensation to a family trust, resulting in no direct ownership of shares by the director.
Summary
- William H. Chang, a director at Semler Scientific, amended a previous SEC filing to reflect changes in his beneficial ownership of company stock.
- The amendment clarifies that 1,318 shares of common stock, initially awarded to Mr. Chang as director compensation, were immediately gifted to the W&D Chang Family Trust.
- As a result of this transaction, Mr. Chang no longer directly owns any shares of Semler Scientific stock, with his beneficial ownership now held indirectly through the family trust.
- The original transaction date was November 7, 2024, and the amendment was filed on January 7, 2025.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, indicating no significant positive or negative sentiment. The transfer of shares to a family trust is a common practice and does not suggest any change in the company's outlook.
Industry Context
This type of filing is common for corporate insiders and directors who receive stock as part of their compensation. It is a routine disclosure required by the SEC to ensure transparency in ownership changes.
Comparison to Industry Standards
- The reporting of changes in beneficial ownership by directors is a standard practice across all publicly traded companies in the US.
- The use of family trusts to hold shares is a common method for estate planning and asset management among corporate insiders.
- The transaction itself is not unusual, and the reporting is consistent with SEC regulations.
Related Party Transactions
- The transfer of shares to the W&D Chang Family Trust is a related party transaction.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a transfer of ownership from the director to his family trust, not a sale of shares on the open market.
- The filing ensures transparency for all stakeholders regarding the ownership of company stock.
Key Dates
| Date | Description |
|---|---|
| 11/07/2024 | Date of the original transaction where shares were awarded and transferred. |
| 11/12/2024 | Date of the original filing. |
| 01/07/2025 | Date of the amended filing. |
Keywords
Semler Scientific, beneficial ownership, director compensation, family trust, SEC filing, stock transfer, SMLR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.